Zhongguo Linchuang YixueObjectiveTo explore the difference of efficacy and safety between denosumab and zoledronic acid in the treatment of patients with postmenopausal osteoporosis (PMOP), and to optimize the medication regimen for PMOP patients.
Jing ZHOU +3 more
doaj +1 more source
Indian Journal of Endocrinology and Metabolism, 2017 Background: Hungry bone syndrome is a common complication of surgery for primary hyperparathyroidism in India which often leads to prolonged hospitalization. There are varying reports on the use and efficacy of bisphosphonates in the prevention of hungry
Sabaretnam Mayilvaganan +2 more
doaj +1 more source
RTOG 0518: Randomized Phase III Trial to Evaluate Zoledronic Acid for Prevention of Osteoporosis and Associated Fractures in Prostate Cancer Patients [PDF]
, 2014 Background: RTOG 0518 evaluated the potential benefit of zoledronic acid therapy in preventing bone fractures for patients with high grade and/or locally advanced, non-metastatic prostate adenocarcinoma receiving luteinizing hormone-releasing hormone ...
Gore, Elizabeth +9 more
core +1 more source
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study [PDF]
, 2013 Owing to the limited validity of clinical data on the treatment of prostate cancer (PCa) and bone metastases, biochemical markers are a promising tool for predicting survival, disease progression and skeletal-related events (SREs) in these patients ...
Alcaraz, A. +42 more
core +2 more sources
Scientific Reports, 2019 Inhibiting osteoclasts and osteoclast precursors to reduce bone resorption is an important strategy to treat osteoclast-related diseases, such as peri-prosthetic osteolysis. In this study, our objective was to study the role of zoledronic acid (ZA), as a
Mei Li +5 more
semanticscholar +1 more source
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. [PDF]
, 2015 Background: Primary hyperparathyroidism (PHPT) is often found on routine blood tests, at a relatively asymptomatic stage. However many studies suggest different systemic effects related to PHPT, which could be enhanced by an abnormal cortisol release due
Armanini, Decio +6 more
core +2 more sources
Use of Zoledronic Acid in the Treatment of Paget's Disease [PDF]
, 2011 This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in
Krane, Stephen Martin +1 more
core
Severe increase in creatinine with hypocalcaemia in thalidomide‐treated myeloma patients receiving zoledronic acid infusions [PDF]
, 2002 Stephen G. Jones +3 more
openalex +1 more source
Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
Therapeutics and Clinical Risk Management, 2009 Roland D ChapurlatINSERM U831, Université de Lyon, Division of Rheumatology, Hôpital E Herriot, Hospices Civils de Lyon, Lyon, FranceBackground: Several treatments for postmenopausal osteoporosis have been available in the past ...
Rol, D Chapurlat
doaj